Environmental Enrichment Induces Behavioral Recovery and Enhanced Hippocampal Cell Proliferation in an Antidepressant-Resistant Animal Model for PTSD

Jolanda Prins, Berend Olivier, Ronald S. Oosting

PLoS ONE

Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: Comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors

Bas Blits, Sanne Derks, Jaap Twisk, +3

Journal of Neuroscience Methods

Viral ReplicationMolecular VirologyAav SerotypesTransduction PropertiesVirology +6

Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice

Floor van Heesch, Jolanda Prins, G.A.H. Korte-Bouws, +5

Behavioural Brain Research

PsychoneuroimmunologyPsychiatryNeurophysiologyMedicineNeuroendocrine Disorder +11

Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: An intracranial self-stimulation study

Floor van Heesch, Jolanda Prins, Jan Pieter Konsman, +4

Brain Behavior and Immunity

NeurophysiologyNeuroanatomyIntracranial Self-stimulation StudyPhysiologyNeurotransmitter +10

Lipopolysaccharide increases degradation of central monoamines: An in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice

Floor van Heesch, Jolanda Prins, Jan Pieter Konsman, +6

European Journal of Pharmacology

Vivo Microdialysis StudyPsychoactive DrugNeurophysiologyNeuroanatomyBehavioral Neuroscience +12

The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats

Jolanda Prins, Damiaan Denys, Koen G.C. Westphal, +6

European Journal of Pharmacology

Psychoactive DrugPsychiatryNeuroanatomyAddictionTriple Reuptake Inhibitor +10

The Novel Triple Reuptake Inhibitor JZAD-IV-22 Exhibits an Antidepressant Pharmacological Profile without Locomotor Stimulant or Sensitization Properties

Barbara J. Caldarone, Neil E. Paterson, Jia Zhou, +8

Journal of Pharmacology and Experimental Therapeutics

The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: A microdialyis study in olfactory bulbectomized rats

Jolanda Prins, Koen G.C. Westphal, G.A.H. Korte-Bouws, +4

Pharmacology Biochemistry and Behavior

Molecular PharmacologyPsychiatryNeurophysiologyMedicinePsychotropic Medication +12

The 5-HT1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and “waiting” impulsivity, but increases “stopping” impulsivity

S. Mechiel Korte, Jolanda Prins, Filip S. van den Bergh, +8

European Journal of Pharmacology

Behavioral NeuroscienceAddictionPrefrontal CortexBehavioral PharmacologyPharmacology +13

The triple reuptake inhibitor DOV 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in rats

Jolanda Prins, Paul J. Kenny, Ivo Doomernik, +3

European Journal of Pharmacology

Brain Reward ActivityNeurophysiologyInduces Long-lasting EnhancementAffective NeuroscienceNeuropharmacology +9